Treatment of Chronic Hepatitis C in a Patient Affected by Systemic Sclerosis

Table 1

Disease activity parameters.

Variable	3 months before IFN therapy	2 months before IFN therapy	1 month before IFN therapy	1 week before IFN therapy	4th weeks of therapy	At the end of IFN	24 months after IFN
FVC (% predicted)				+0%		−10%	+0%
DLCO (% predicted)				−29%		−40%	−20%
White cells count ×10^9				7		3.2	6.6
Red cells count ×10^12				4.66		4.2	4.62
Hg (g/dl)				13.4		12	13
Platelet count ×10^9				215		194	243
RCP				0.34		0.3	0.3
Creatinine (mg/dl)				0.89		0.6	0.7
ALT (IU/L)	857	437	237	241	36
AST (IU/L)	424	291	156	168	36
AP (IU/L)	422	344	291	275
GGT (IU/L)	288	187	115	110
Bilirubin (mg/dl)	0,4		0.4	0.3	0,3
HCV-RNA viremia (IU/ml)				3131760	<50	<50	<50